I did post the name of the guideline recently Andrew, but I’m on the run at the moment. in short, NO, the types of things that BOT have to address were NOT a clear wrongdoing or failure. As the expert FDA lawyer said, it just comes down to a judgement call from FDA, and if that’s what they want…
BOT - Anything but charting, page-6491
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.8¢ |
Change
-0.003(0.78%) |
Mkt cap ! $567.9M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.0¢ | $1.164M | 3.701M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 208186 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 1053880 | 33 |
View Market Depth
| Last trade - 15.13pm 18/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |